Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lu

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Drug Delivery and Translational Research|March 8, 2021
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia preventionAmin GhavamiNejad, Brian Lu, Melisa Samarikhalaj, et al.
Pancreas|November 15, 2016
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 StudyVolker Kunzmann, Ramesh K Ramanathan, David Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2022
The UVSSA protein is part of a genome integrity homeostasis network with links to transcription-coupled DNA repair and ATM signalingMagdalena M Kordon, Sarah Arron, James E Cleaver, et al.
Drug Delivery and Translational Research|April 22, 2017
Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devicesJason Li, Michael K Chu, Brian Lu, et al.
Open Forum Infectious Diseases|June 18, 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center ExperienceBrian Lu, David Ha, Sa Shen, et al.
Clinical Pharmacology and Therapeutics|June 11, 2021
Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and AtorvastatinBrian Lu, Laura Sun, Manuel Seraydarian, et al.
Acta Pharmacologica Sinica|April 27, 2018
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examplesRui Xue Zhang, Jason Li, Tian Zhang, et al.
BMC Research Notes|December 10, 2017
Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell populationSalma G Morsy, Jason M Tonne, Yaxi Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)David Goldstein, Daniel D Von Hoff, Malcolm Moore, et al.
Frontiers in Oncology|January 24, 2022
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid TumorsMichael S Gordon, Geoffrey I Shapiro, John Sarantopoulos, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Drug Delivery and Translational Research|March 8, 2021
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia preventionAmin GhavamiNejad, Brian Lu, Melisa Samarikhalaj, et al.
Pancreas|November 15, 2016
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 StudyVolker Kunzmann, Ramesh K Ramanathan, David Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2022
The UVSSA protein is part of a genome integrity homeostasis network with links to transcription-coupled DNA repair and ATM signalingMagdalena M Kordon, Sarah Arron, James E Cleaver, et al.
Drug Delivery and Translational Research|April 22, 2017
Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devicesJason Li, Michael K Chu, Brian Lu, et al.
Open Forum Infectious Diseases|June 18, 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center ExperienceBrian Lu, David Ha, Sa Shen, et al.
Clinical Pharmacology and Therapeutics|June 11, 2021
Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and AtorvastatinBrian Lu, Laura Sun, Manuel Seraydarian, et al.
Acta Pharmacologica Sinica|April 27, 2018
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examplesRui Xue Zhang, Jason Li, Tian Zhang, et al.
BMC Research Notes|December 10, 2017
Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell populationSalma G Morsy, Jason M Tonne, Yaxi Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2015
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)David Goldstein, Daniel D Von Hoff, Malcolm Moore, et al.
Frontiers in Oncology|January 24, 2022
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid TumorsMichael S Gordon, Geoffrey I Shapiro, John Sarantopoulos, et al.
Pageof 5